Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19
VANCOUVER, British Columbia, Oct. 30, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.&nb...